Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1
Ping Luo, Shugui Wu, Kaibao Ji, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0223035-e0223035
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Gholami, et al.
Pharmacological Research (2021) Vol. 167, pp. 105575-105575
Closed Access | Times Cited: 121
Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
Sepideh Mirzaei, Kiavash Hushmandi, Amirhossein Zabolian, et al.
Molecules (2021) Vol. 26, Iss. 8, pp. 2382-2382
Open Access | Times Cited: 98
Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1
Baocheng Xie, Pei‐Shan Wu, Hongyu Liu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment
Xinyi Yang, Yingchao Liu, Jie Cao, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
Chenming Zhong, Zijun Xie, Linghui Zeng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Mechanism of Action and Therapeutic Implications of Nrf2/HO-1 in Inflammatory Bowel Disease
Lingling Yuan, Yingyi Wang, Na Li, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 1012-1012
Open Access | Times Cited: 8
LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin
Mohammad Taheri, Hamed Shoorei, Farhad Tondro Anamag, et al.
Experimental and Molecular Pathology (2021) Vol. 123, pp. 104602-104602
Closed Access | Times Cited: 39
Comprehensive Analysis of Immune Infiltrates of Ferroptosis-Related Long Noncoding RNA and Prediction of Colon Cancer Patient Prognoses
Wen-Zheng Chen, Yafei Chen, Li Liu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 25
Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
Majid Ghasemian, Masoumeh Rajabibazl, Unes Sahebi, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 21
The Dual Role of NRF2 in Colorectal Cancer: Targeting NRF2 as a Potential Therapeutic Approach
Mengyun Hu, Lingling Yuan, Jie Zhu
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5985-6004
Open Access | Times Cited: 4
Activation of anti-oxidant Keap1/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation
Sina Bader, Julia Wilmers, Martin Pelzer, et al.
Free Radical Biology and Medicine (2021) Vol. 168, pp. 44-54
Closed Access | Times Cited: 27
Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer
Jie Mei, Huixiang Tian, Xiaoye Zhang, et al.
Journal of Advanced Research (2025)
Open Access
The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer
Isaac Micallef, Byron Baron
Non-Coding RNA (2021) Vol. 7, Iss. 2, pp. 24-24
Open Access | Times Cited: 23
Downregulation of long non‑coding RNA MR4435‑2HG suppresses breast cancer progression via the Wnt/β‑catenin signaling pathway
Deqin Chen, Pengting Tang, Yike Wang, et al.
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 21
MIR4435-2HG: A newly proposed lncRNA in human cancer
Menggang Zhang, Xiao Yu, Qiyao Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112971-112971
Open Access | Times Cited: 16
Nrf2 in human cancers: biological significance and therapeutic potential
Yu Tian, Lixin Tang, Xin Wang, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 3935-3961
Closed Access | Times Cited: 2
Identification of Autophagy- and Ferroptosis-Related lncRNAs Functioned through Immune-Related Pathways in Head and Neck Squamous Carcinoma
Qi Guo, Xuehan Zhang, Tao Shen, et al.
Life (2021) Vol. 11, Iss. 8, pp. 835-835
Open Access | Times Cited: 15
Reactive Oxygen Species and Long Non-Coding RNAs, an Unexpected Crossroad in Cancer Cells
Teodor Paul Kacso, Renata Zahu, Alexandru Tirpe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10133-10133
Open Access | Times Cited: 11
TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers
Melika Golozar, Ali Valipour Motlagh, Mohammad Mahdevar, et al.
Experimental and Molecular Pathology (2024) Vol. 136, pp. 104890-104890
Open Access | Times Cited: 2
Long Non-Coding RNA: A Potential Strategy for the Diagnosis and Treatment of Colorectal Cancer
Shanshan Chen, Yi Fang, Lingyu Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway
Wenjing Shi, Liqun Ling, Changhong Li, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 3, pp. 1295-1311
Closed Access | Times Cited: 9
Natural products: Potential targets of TME related long non-coding RNAs in lung cancer
Rama Rao Malla, Vasudevaraju Padmaraju, Rakshmitha Marni, et al.
Phytomedicine (2021) Vol. 93, pp. 153782-153782
Closed Access | Times Cited: 10
Interplay between Non-Coding RNAs and NRF2 in Different Cancers: Spotlight on MicroRNAs and Long Non-Coding RNAs
İlhan Yaylım, Ammad Ahmad Farooqı, Pelin Telkoparan‐Akillilar, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 28-34
Open Access | Times Cited: 7
MIR4435-2HG: A Tumor-associated Long Non-coding RNA
Fangnan Zhao, Yuling Liu, Fangshun Tan, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 25, pp. 2043-2051
Closed Access | Times Cited: 4
Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
Zhou Chen, Defeng Guan, Qiangping Zhu, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8864-8881
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top